AXGN
Axogen, Inc.
Key Financials
Revenue
$225.2M
↑ 20.2%
Gross Profit
$167.4M
↑ 17.9%
Operating Income
$-7849000
↓ 138.8%
Net Income
$-15703000
↓ 57.6%
Total Assets
$221.7M
↑ 8.8%
EPS (Diluted)
$-0.34
↓ 47.8%
Shareholders' Equity
$128.8M
↑ 24.0%
Total Liabilities
$92.8M
↓ 7.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/12/2026 | View on SEC |
| 144 | 5/8/2026 | View on SEC |
| 4 | 5/8/2026 | View on SEC |
| 4 | 5/8/2026 | View on SEC |
| 4 | 5/8/2026 | View on SEC |
| 4 | 5/8/2026 | View on SEC |
| 4 | 5/8/2026 | View on SEC |
| 3 | 5/8/2026 | View on SEC |
| 144 | 5/7/2026 | View on SEC |
| 144 | 5/7/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AXGN |
| Company Name | Axogen, Inc. |
| CIK | 805928 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | MN |
| Phone | (386) 462-6817 |